NEOVACS Employee Directory
Biotechnology ResearchÎle-de-france, France11-50 Employees
NEOVACS is a French biotechnology company focused on developing therapeutic vaccines for autoimmune and inflammatory diseases. Its immunotherapy programs aim to modulate the immune system and potentially alter disease progression in patients. The firm operates within the biotechnology research landscape, pursuing preclinical and therapeutic development activities. Based in Suresnes, in the Île-de-France region, NEOVACS is a small-to-mid-sized organization focused on immunomodulatory vaccines. Its work targets immune dysfunction associated with conditions such as type 1 diabetes and inflammatory dermatoses, with collaboration and research partnerships as a potential pathway to bringing therapies forward. A 2019 report noted that the company was developing a preclinical vaccine that could halt disease progression in recently diagnosed type 1 diabetes patients.
1-888-653-2347 
support@leadiq.com 
